medicines
-
7-Oct-2019 Fundación Grupo Efecto Positivo
Conversatorio ¿Qué pasará con el TLC UE-Mercosur y los PCT?
Conversatorio sobre Soberanía y Derechos Humanos para debatir en torno a los Acuerdos Internacionales, Tratados de Libre Comercio y economía.
-
25-Sep-2019 The Wire
As Modi visits US, what does the free trade pact mean for India’s pharma industry?
A Free Trade Agreement with the US will likely result in the amendment of the Patents Act, which could impact the Indian pharma industry.
-
11-Sep-2019 CityNews
US farmers’ group says pharma, not dairy, is main obstacle to ratifying USMCA
The National Farmers Union says the new deal’s extended patent protection for new pharmaceuticals must be reduced so that less expensive generic versions of new drugs can be available to consumers sooner.
-
11-Sep-2019 Radio Canada
Libre-échange : des agriculteurs américains s’inquiètent de l’accès aux soins de santé
La National Farmers Union affirme que la protection élargie des brevets pour les nouveaux produits pharmaceutiques doit être réduite.
-
15-Jul-2019 The European Sting
EU-US trade talks: milestone reached in mutual recognition on pharmaceuticals
The mutual recognition agreement for inspections of manufacturing sites for human medicines in their respective territories can make it faster and less costly for both sides to bring medicines to the market.
-
3-Jul-2019 Make Medicines Affordable
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement (FTA).
-
2-Jul-2019 The Times of India
India protects drug, agriculture business at RCEP
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
-
25-Jun-2019 FTA Watch
Thai CSOs’ proposition against IP enforcement in the RCEP negotiation
FTA Watch would like to urge the Thai negotiation team for the RCEP to have a strong position to reject proposals on Intellectual Property Enforcement chapter.
-
29-May-2019 CBC
NAFTA bill lets Trudeau cabinet wait and see what US Congress does Social Sharing
US Democrats fear higher drug prices, trying to change text of trade deal
-
27-May-2019 Red Pepper
Free trade can seriously damage your health
These practises open the door to Big Pharma companies and disastrous private health companies.
-
30-Apr-2019 Le Monde
En Tunisie, un accord avec l’UE menace de faire flamber le prix des médicaments
Les fabricants de génériques s’inquiètent de la possible prolongation des brevets européens.
-
17-Apr-2019 El Desconcierto
El TPP11 y la pérdida de la soberanía
Me opongo al TPP11, porque no quiero que se extiendan las patentes de los medicamentos de 5 a 8 años, encareciendo aún más el acceso a fármacos que salvan vidas o alivian los dolores a miles de chilenos que padecen de enfermedades catastróficas o terminales.
-
16-Apr-2019 Project Syndicate
Will free trade make Africans sick?
African governments must act immediately to address the AfCFTA’s potential negative implications for Africans’ health.
-
4-Apr-2019 KEI
2019: USTR takes aim at European countries over pharmaceutical pricing and reimbursement policies
In its latest report on foreign trade barriers, the USTR, prompted by the pharmaceutical industry, takes aim at the pharmaceutical pricing and reimbursement policies in the European Union.
-
3-Apr-2019 Council of Canadians
PBO report shows that new NAFTA provisions threaten Pharmacare, says Council of Canadians
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
-
1-Apr-2019 NY Magazine
Trump’s NAFTA 2.0 puts big pharma first, America second
The new version of NAFTA forbids the US Congress from curtailing Big Pharma’s patent monopolies on some of the world’s most expensive drugs.
-
25-Mar-2019 Chile Mejor sin TLC
Chile: Bancada transversal #NoAlTPP en gestación
La semana que se inicia el lunes 25 podría ser decisiva para consolidar un voto transversal contra el TPP, construido a pulso social.
-
22-Mar-2019 Fundación GEP
TLC: Sin remedio(s) para el Mercosur, cerró la 38va ronda de negociación del acuerdo comercial con la Unión Europea
Si bien el Ministerio de Relaciones Exteriores de Argentina comunicó que la ronda 38va de negociaciones entre el Mercosur y la Unión Europea culminó luego de “discusiones constructivas y progresos al nivel de los jefes negociadores”, fuentes informaron que en materia del capítulo de propiedad intelectual el Mercosur mostró una postura “muy flexible” al aceptar los términos impuestos por la UE.
-
21-Mar-2019 El Desconcierto
Chile: Los argumentos falaces del gobierno para empujar al Congreso a aprobar el TPP-11
La Cancillería y su Dirección General de Relaciones Económicas Internacionales (DIRECON), se están defendiendo del mar de críticas contra el Tratado Integral y Progresista de Asociación Transpacífico (CPTPP), conocido como TPP-11, a punta de argumentos engañosos y derechamente falsos.
